Patient noncompliance with self‐administered chemotherapy

Cancer

Volumn 65, Issue 1, 1990, Pages 17-22

  Lebovits, Allen H ^a   Strain, James J ^b   Messe, Madeline R ^b   Schleifer, Steven J ^c   Tanaka, Jeffrey S ^d   Bhardwaj, Sushil ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SELF MEDICATION;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMAN; PATIENT COMPLIANCE; SELF ADMINISTRATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025138455     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I     Document Type: Article

References (36)

1. The direct effects of compliance on health outcome
2. Dose‐response effect of adjuvant chemotherapy in breast cancer
3. The drug defaulter
4. Drug therapy: Patient compliance
5. The magnitude of compliance and noncompliance
6. Variations in patients' compliance with doctors orders: Analysis of congruence between survey responses and results of empirical investigations
7. Acute toxicity during adjuvant chemotherapy for breast cancer: The National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents
8. Compliance with chemotherapy among breast cancer patients
9. Five‐drug adjuvant chemotherapy for breast cancer
10. Adjuvant chemotherapy (CMF) for breast carcinoma: Patient's compliance and total dose achieved
11. Patient compliance with aggressive multimodal therapy in locally advanced breast cancer
12. Oncology clinic attendance at an inner city hospital
13. Path model of multidimensional compliance with cancer therapy
14. A reliable method for evaluating drug compliance in children with cancer
15. Compliance of pediatric and adolescent cancer patients
16. Research diagnostic criteria: Rationale and reliability
17. Mini‐Mental State
18. Screening devices for diminished cognitive capacity
19. The SCL‐90: An outpatient psychiatric rating scale‐preliminary report
20. Dosage record and treatment emergent symptom scales (DOTES)
21. The existential plight in cancer: Significance of the first 100 days
22. Broken appointments
23. A multivariate approach of no‐show behavior in a primary care center
24. How well do patients take oral penicillin
25. Communication, compliance, and concordance between physicians and patients with prescribed medications
26. Satisfaction, compliance and communication
27. Behavioral strategies of improving compliance
28. Cognitive predictors of compliance in chronic disease patients
29. Compliance and noncompliance in cancer patients
30. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5‐Fu (CMF) adjuvant chemotherapy for breast carcinoma
31. An evaluation of a new patient compliance index using plasma propranolol levels